Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA and other cellular components represent a broad category of biological targets that are not specific proteins, but rather the fundamental building blocks of the cell, most notably deoxyribonucleic acid (DNA). DNA serves as the primary repository of genetic information, and its integrity is essential for cellular function, replication, and survival (Source: NIH). Many traditional chemotherapeutic agents, such as alkylating agents and platinum-based compounds, target DNA by forming covalent bonds or intercalating between base pairs, which inhibits replication and triggers programmed cell death (Source: StatPearls). While highly effective against rapidly proliferating cancer cells, these interactions are generally non-specific and can damage the DNA of healthy tissues, leading to significant toxicities (Source: PubMed). Beyond DNA, this category may include other macromolecules like RNA or structural lipids that are affected by certain non-specific cytotoxic or antiseptic agents. Consequently, while these targets are clinically validated, the lack of specificity remains a major challenge in modern drug design (Source: NIH).
Drugs targeting DNA typically act through covalent modification (alkylation), cross-linking of strands, or non-covalent intercalation between base pairs, all of which physically obstruct the machinery required for DNA replication and transcription (Source: StatPearls). These actions lead to the formation of DNA adducts and double-strand breaks, which activate DNA damage response pathways and, if the damage is irreparable, trigger apoptosis (Source: PubMed). Some agents also generate reactive oxygen species that cause oxidative damage to DNA and other cellular components like lipids and proteins (Source: NIH).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA and other cellular components (DNA).